RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials
Authors
Keywords
RAAS, ACE-inhibitor, ARB, Cardioprotection, Hypertension, Heart failure
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume 27, Issue 2, Pages 171-179
Publisher
Springer Nature
Online
2012-12-06
DOI
10.1007/s10557-012-6424-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection?
- (2012) F. Ruschitzka et al. EUROPEAN HEART JOURNAL
- Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients
- (2012) L. C. van Vark et al. EUROPEAN HEART JOURNAL
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
- (2012) John J.V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
- Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)
- (2012) Hans-Henrik Parving et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Heart failure—does it matter whether LVEF is reduced?
- (2012) John GF Cleland et al. LANCET
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
- (2011) Akshay S. Desai et al. AMERICAN HEART JOURNAL
- Concomitant Angiotensin AT1 Receptor Antagonism and Neprilysin Inhibition Produces Omapatrilat-like Antihypertensive Effects Without Promoting Tracheal Plasma Extravasation in the Rat
- (2011) Laxminarayan G Hegde et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)
- (2010) Faiez Zannad et al. EUROPEAN JOURNAL OF HEART FAILURE
- Rationale and design of the ‘aldosterone receptor blockade in diastolic heart failure’ trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in pa
- (2010) Frank Edelmann et al. EUROPEAN JOURNAL OF HEART FAILURE
- Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)
- (2010) Mihai Gheorghiade et al. EUROPEAN JOURNAL OF HEART FAILURE
- Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOS
- (2010) Henry Krum et al. EUROPEAN JOURNAL OF HEART FAILURE
- Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study
- (2010) Luis Miguel Ruilope et al. LANCET
- Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
- (2009) Jessie Gu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
- (2009) Marvin A Konstam et al. LANCET
- Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure
- (2009) Christopher Newton-Cheh et al. NATURE GENETICS
- Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
- (2009) H.-H. Parving et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction
- (2008) B. R. Palmer et al. EUROPEAN HEART JOURNAL
- Global perceived health and ten-year cardiovascular mortality in elderly primary care patients with possible heart failure
- (2008) Peter Johansson et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension
- (2008) David A. Calhoun et al. Journal of the American Society of Hypertension
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now